Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kojamo plc: Lumo Kodit and Jatke Uusimaa Oy agree on the construction of 77 new homes in Kontula, Helsinki

Kojamo plcPress release 30 October 2020 at 12.30 p.m.Kojamo plc: Lumo Kodit and Jatke Uusimaa Oy agree on the construction of 77 new homes in Kontula, Helsinki Lumo Kodit Oy and Jatke Uusimaa Oy have agreed on the construction of 77 apartments in Kontula, Helsinki. An eight-storey building will be constructed at Keinutie 9d. The Keinutie property is an infill development project, which produces a lower carbon footprint than building a new property on an unbuilt plot. The area has good transport links, including a metro station, and it also has a shopping centre, schools and day care

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release October 30, 2020, at 12:10 p.m.  Nokian Tyres has received an announcement from BlackRock, Inc. on October 29, 2020, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement BlackRock, Inc.'s indirect holding in Nokian Tyres shares fell below the level of 5% of the share capital in Nokian Tyres plc, as a result of share transactions concluded on October 28, 2020. The indirect shareholding of BlackRock, Inc. in Nokian Tyres has decreased to 6,794,019 shares, corresponding to 4.89% of Nokian Tyres’

EAB Group Plc: Managers’ Transactions

EAB Group Plc, Stock Exchange Release, 30 October 2020, 12:10 (EET) EAB Group Plc: Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: PIELA TOPI Position: Member of the Board/Deputy member (X) Legal person Issuer: EAB Group Oyj LEI: 743700B4GXTH5JBZ6318 Notification type: INITIAL NOTIFICATION Reference number: 743700B4GXTH5JBZ6318_20201029130916_2 ____________________________________________ Transaction date: 2020-10-28 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE

EAB Group Plc: Managers’ Transactions

EAB Group Plc, Stock Exchange Release, 30 October 2020, 12:10 (EET) EAB Group Plc: Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: TYNKKYNEN JUHA Position: Member of the Board/Deputy member (X) Legal person Issuer: EAB Group Oyj LEI: 743700B4GXTH5JBZ6318 Notification type: INITIAL NOTIFICATION Reference number: 743700B4GXTH5JBZ6318_20201029131151_2 ____________________________________________ Transaction date: 2020-10-28 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE

Saga Tankers Asa: Share Capital Increases Registered

Reference is made to the stock exchange notices from Saga Tankers ASA (the "Company") dated 19 October 2020 and 20 October 2020 regarding completion of two private placements of new shares in the Company. The private placement completed on 19 October 2020 (the "Private Placement I") consisted of an issuance of 20,000,000 new shares in the Company. The private placement completed on 2020 October (the "Private Placement II") consisted of an issuance of 54,000,000 new shares in the Company. The share capital increases pertaining to the Private Placement I and the Private Placement II has

BioStock: CombiGene comments the final preclinical steps

The gene therapy company CombiGene, which is developing a new treatment for drug-resistant focal epilepsy, is planning to focus on the final preclinical studies next year and then begin the first study in humans in 2022. BioStock turned to CEO Jan Nilsson for a status update and to talk about what remains to be done before the preclinical program can be terminated.Read the full interview with CombiGene's CEO Jan Nilsson at biostock.se: https://www.biostock.se/en/combigene-comments-the-final-preclinical-steps/ This is a pressrelease from BioStock - Connecting Innovation & Capital.

EAB Group Plc: Managers’ Transactions

EAB Group Plc, Stock Exchange Release, 30 October 2020, 12:05 (EET) EAB Group Plc: Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: KOHMO PASI Position: Member of the Board/Deputy member (X) Legal person Issuer: EAB Group Oyj LEI: 743700B4GXTH5JBZ6318 Notification type: INITIAL NOTIFICATION Reference number: 743700B4GXTH5JBZ6318_20201029130550_2 ____________________________________________ Transaction date: 2020-10-28 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE

Nomination committee in IRLAB appointed ahead of annual general meeting 2021

IRLAB (Nasdaq Stockholm: IRLAB A) announced today that in preparation for the annual general meeting 2021, the company’s three largest shareholders, or groups of shareholders, have appointed members of the nomination committee. The nomination committee consists of Daniel Johnsson, Bo Rydlinger and Clas Sonesson beside Gunnar Olsson, the chairman of the board. The nomination committee represents about 53 percent of shares and votes in the company.According to the instruction for appointment of the nomination committee in IRLAB Therapeutics AB, resolved at the annual general meeting on May 7,

EAB Group Plc: Managers’ Transactions

EAB Group Plc, Stock Exchange Release, 30 October 2020, 12:00 (EET) EAB Group Plc: Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: BORSOS JULIANNA Position: Member of the Board/Deputy member (X) Legal person Issuer: EAB Group Oyj LEI: 743700B4GXTH5JBZ6318 Notification type: INITIAL NOTIFICATION Reference number: 743700B4GXTH5JBZ6318_20201029132838_3 ____________________________________________ Transaction date: 2020-10-28 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE

EAB Group Plc: Managers’ Transactions

EAB Group Plc, Stock Exchange Release, 30 October 2020, 12:00 (EET) EAB Group Plc: Managers’ Transactions ____________________________________________ Person subject to the notification requirement Name: CEDERCREUTZ THERESE Position: Member of the Board/Deputy member (X) Legal person Issuer: EAB Group OYj LEI: 743700B4GXTH5JBZ6318 Notification type: INITIAL NOTIFICATION Reference number: 743700B4GXTH5JBZ6318_20201029132913_3 ____________________________________________ Transaction date: 2020-10-28 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type:

Complementary to press release ” I.A. Hedin Bil AB interim report Q3 2020 ”

Complementary: This press release is a complementary to the press release “I.A. Hedin Bil AB interim report Q3 2020” published 2020-10-30 kl. 10.00. The PDF generated press release was attached two times. In this update the interim report as a PDF is attached. Please find the prior press release below:I.A. Hedin Bil AB interim report Q3 2020 Hedin Bil delivers a strong quarter with focus on cost savings and liquidity. Gothenburg, 30th of October 2020 Operating profit during the third quarter was 240 MSEK, which was an improvement of 131 percent compared to last year’s third quarter.

NAUTIZ handhelds streamline public safety

Streamwide is a global technology provider offering mission critical communications and operations solutions. Its platforms address a specific pain point for mobile teams: the gap that can result between individual mobile connectivity and true team synergy. “The more virtually together we can be, the more physically distant and split between different apps we are,” Streamwide says on its website. “The ultimate challenge for demanding missions and jobs is building teams that turn individual contribution into collective achievements.” Nowhere is this more relevant than for public safety

Shawbrook Bank shows its commitment to racial equality by signing up to the Race at Work Charter

Business in the Community (BITC) in partnership with the government is pleased to announce that Shawbrook Bank has signed up to the Race at Work Charter, an initiative designed to improve outcomes for black, Asian and minority ethnic (BAME) employees in the UKThe specialist bank joins a growing list of more than 200 public, private and charitable organisations in signing up to the Charter. The Charter builds on the work of the 2017 McGregor-Smith Review, ‘Race in the workplace’, a wake-up call for UK employers, which found that people from BAME backgrounds were still underemployed,

Adapteo completes the acquisition of Dutch Cabin Group, a Dutch company specialised in adaptable buildings

Adapteo Plc Press release 30 October 2020 at 10:10 a.m. CET Adapteo has completed the acquisition of Dutch Cabin Group. The company manufactures, rents out, and sells both temporary and permanent buildings to customers within the governmental, educational, industrial and healthcare sectors. Dutch Cabin Group has around 120 employees and is headquartered in Klundert, Netherlands. Dutch Cabin Group operates with six brands in the Netherlands and Germany and has two inhouse production sites in the Netherlands. In the fiscal year of 2019, Dutch Cabin Group had revenues of EUR 50.7

Gasum Group Q3 2020 – Demand for gas solutions remained steady

Key financial indicators January 1 to September 30, 2020*·Group operating profit totaled €12.8 million, down 43.1% year on year (September 30, 2019: €22.4 million) ·Operating profit margin in the reporting period was 2.8%, down 0.4 percentage points compared with the reference year’s continuing operations (September 30, 2019: 3.2%) ·Balance sheet total came to €1,256.1 million (September 30, 2019: €1,075.9 million) ·The Group’s solvency remained strong in the reporting period, with the equity ratio at 38.8% (September 30, 2019: 45.2%) * Including comparable figures

Exel Composites' financial calendar and Annual General Meeting in 2021

EXEL COMPOSITES PLC                STOCK EXCHANGE RELEASE                30 OCTOBER 2020 11:00 EETExel Composites Plc will publish the following financial reports in 2021:  · Financial Statements Release 2020: 18 February 2021 at approximately 9:00 EET · Business Review Q1 2021: 30 April 2021 at approximately 9:00 EET · Half Year Financial Report Q1-Q2 2021: 20 July 2021 at approximately 10:00 EET · Business Review Q1-Q3 2021: 4 November 2021 at approximately 9:00 Annual Financial Report, including the Report of the Board the Directors as well as the financial statements,

Integrum’s OPRA™ Implant System now available at Froedtert & the Medical College of Wisconsin

Orthopaedic services at Froedtert & Medical College Wisconsin now include the OPRA™ Implant System for above-knee amputations.The Froedtert & the Medical College of Wisconsin health network is now using the OPRA™ Implant System, Integrum’s bone-anchored solution for the rehabilitation of amputees. The Froedtert & the Medical College of Wisconsin regional health network is a partnership between Froedtert Health and the Medical College of Wisconsin. The health network includes five hospitals, more than 1,700 physicians, and nearly 40 health centers and clinics, drawing patients from

I.A. Hedin Bil AB interim report Q3 2020

Hedin Bil delivers a strong quarter with focus on cost savings and liquidity.Gothenburg, 30th of October 2020 Operating profit during the second quarter was 240 MSEK, which was an improvement of 131 percent compared to last year’s third quarter. Net sales in comparable units increased by 21 percent compared to the same period last year. The operations in Sweden and Norway improved both operating profit and operating margin. The Belgian operations returned to show a profit after second quarter’s loss. New car sales increased by 2 percent in comparable units and the gross margin

Herantis Pharma Oyj : Managers' Transactions – Mats Heiman

Herantis Pharma Plc Company release 30 Oct 2020 at 9:00 am EET Herantis Pharma Oyj – Managers’ Transactions____________________________________________ Person subject to the notification requirement Name: Heiman, Mats Position: Closely associated person (1): Person Discharging Managerial Responsibilities In Issuer Name: Atteryd Heiman, Ingrid Position: Member of the Board Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20201029220801_12 _________________________________

Cyxone announces positive results from regulatory toxicology studies of Rabeximod

Cyxone (publ.), a Swedish biotech company developing disease modifying therapies for disorders of the immune system, today announced that the six-month regulatory toxicology studies of its drug candidate Rabeximod has been successfully concluded. A read-out of the study results shows a favorable safety profile for Rabeximod, thus enabling longer clinical studies in patients up to six months. Cyxone will now take the next step toward the initiation of a Phase 2 study in rheumatoid arthritis patients.The concluded six-month toxicology studies in two species are obligatory evaluations demanded

Press release 30.10.2020 New VTT-based startup company eniferBio producing protein from biorefinery by-products received more than one million euros in funding

The growing demand for food and sustainable food production are global challenges. A significant part of the problem is the lack of sustainably produced protein feed. eniferBio has developed a new and sustainable production process for a high-quality fish feed ingredient and recently received funding for its solution from two funds, Nordic FoodTech VC and Voima Ventures.Fish is healthier and more ecological source of protein than meat and its consumption is constantly increasing. The decline in fish stocks has led to the increased fish farming which, in turn, is limited to the availability

Wallenstam introduces digital mailboxes in all new production

Wallenstam is introducing digital mailboxes as standard in all new housing production. The mailboxes will be integrated with the properties’ digital entry system which will give the residents easy and secure access to their homes and their mail. Wallenstam’s existing residential properties, home for 10,000 families, will be included in stage two.“We currently have about 3,000 rental apartments in production. Quality, security and design have been important aspects in our agreement with Renz, which is our partner in this initiative,” says Patrik Persson, Technical Director at Wallenstam.

Change in number of shares and votes in Lagercrantz Group AB

The total number of shares and votes in Lagercrantz Group AB, reg. no. 556282-45556 (“Lagercrantz”) has changed in October 2020 consequent upon the Annual General Meeting in Lagercrantz held on 25 August 2020 resolving on a share split (3:1). Class A sharesBefore split                         Increased by                       New no.                              Total no. of votes3,263,802                           6,527,604                            9,791,406                            97,914,060 Class B shares66,256,125                         132,512,250

Altia: Publication of Q3 2020 Business Review on 6 November 2020 and invitation to a results presentation

Altia Plc  Press release  30 October 2020 at 10:00 am EET Altia: Publication of Q3 2020 Business Review on 6 November 2020 and invitation to a results presentation Altia will publish its Business Review for January–September 2020 on Friday 6 November at around 8:30 am EET. CEO Pekka Tennilä and interim CFO Juhana Jokinen will present the report on the same day at 11:00 am EET. The presentation will be held as a Microsoft Teams Meeting. We recommend that participants join the event using the online meeting option. Option A: Online meeting Access meeting online here: Altia's Q3

There are no items matching the current filter
There are no more items matching the current filter
Back to top